These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 35859033)
1. Physician-Reported Perspectives on Myasthenia Gravis in the United States: A Real-World Survey. Mahic M; Bozorg AM; DeCourcy JJ; Golden KJ; Gibson GA; Taylor CF; Ting A; Story TJ; Scowcroft A Neurol Ther; 2022 Dec; 11(4):1535-1551. PubMed ID: 35859033 [TBL] [Abstract][Full Text] [Related]
2. Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. Mahic M; Bozorg A; DeCourcy J; Golden K; Gibson G; Taylor C; Scowcroft A Orphanet J Rare Dis; 2023 Jun; 18(1):169. PubMed ID: 37386469 [TBL] [Abstract][Full Text] [Related]
3. A real-world analysis of factors associated with high healthcare resource utilization and costs in patients with myasthenia gravis receiving second-line treatment. Ting A; Story T; Lecomte C; Estrin A; Syed S; Lee E J Neurol Sci; 2023 Feb; 445():120531. PubMed ID: 36634582 [TBL] [Abstract][Full Text] [Related]
4. Real-World Treatment Patterns and Outcomes Among Patients with Episodic Migraine in China: Results from the Adelphi Migraine Disease Specific Programme™. Zhao H; Xiao Z; Zhang L; Ford J; Zhong S; Ye W; Li J; Tockhorn-Heidenreich A; Cotton S; Chen C J Pain Res; 2023; 16():357-371. PubMed ID: 36762367 [TBL] [Abstract][Full Text] [Related]
5. Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients. Rosmarin D; Lofland JH; Marwaha S; Piercy J; Anderson P; Liu J Dermatol Ther (Heidelb); 2024 Jun; 14(6):1531-1546. PubMed ID: 38753072 [TBL] [Abstract][Full Text] [Related]
6. Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden. Lancaster L; Bonella F; Inoue Y; Cottin V; Siddall J; Small M; Langley J Respirology; 2022 Jan; 27(1):66-75. PubMed ID: 34611971 [TBL] [Abstract][Full Text] [Related]
7. Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries. Armuzzi A; Hart A; Cappelleri JC; Mammar N; Hur P; Hoskin B; Hennessy F; Milligan G; Dignass A BMC Gastroenterol; 2023 Jan; 23(1):17. PubMed ID: 36658481 [TBL] [Abstract][Full Text] [Related]
9. Impact of the Covid-19 epidemic on a US sample of patients with myasthenia gravis. Gutierrez G; Girma H; Kuhnell P; Macaluso M; Kaminski HJ Ther Adv Rare Dis; 2022; 3():26330040221082673. PubMed ID: 37125217 [TBL] [Abstract][Full Text] [Related]
10. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US. Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469 [TBL] [Abstract][Full Text] [Related]
11. Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey. Merola JF; Ogdie A; Gottlieb AB; Stein Gold L; Flower A; Jardon S; Klyachkin Y; Lebwohl M Dermatol Ther (Heidelb); 2023 Jun; 13(6):1329-1346. PubMed ID: 37183192 [TBL] [Abstract][Full Text] [Related]
12. Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries. Vañó-Galván S; Blume-Peytavi U; Farrant P; Reygagne P; Johansson E; Reed C; Marwaha S; Durand F; Piraccini BM Dermatol Ther (Heidelb); 2023 Dec; 13(12):3121-3135. PubMed ID: 37889388 [TBL] [Abstract][Full Text] [Related]
13. Burden of illness and costs in patients with myasthenia gravis currently receiving treatment in the United States. Parthan A; Royston M; Thanataveerat A; East EL; Parzynski CS; Habib AA Muscle Nerve; 2024 Feb; 69(2):157-165. PubMed ID: 38018505 [TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
15. Exploring the real-world profile of refractory and non-refractory chronic idiopathic urticaria in the USA: clinical burden and healthcare resource use. Hoskin B; Ortiz B; Paknis B; Kavati A Curr Med Res Opin; 2019 Aug; 35(8):1387-1395. PubMed ID: 30793986 [No Abstract] [Full Text] [Related]
16. Disease Course, Treatment Patterns and Goals Among Patients with Non-segmental Vitiligo Across Europe and the United States. Rosmarin D; Soliman AM; Marwaha S; Piercy J; Camp HS; Anderson P; Ezzedine K Dermatol Ther (Heidelb); 2024 Jul; 14(7):1945-1957. PubMed ID: 38926302 [TBL] [Abstract][Full Text] [Related]
17. A decentralized, prospective, observational study to collect real-world data from patients with myasthenia gravis using smartphones. Steyaert S; Lootus M; Sarabu C; Framroze Z; Dickinson H; Lewis E; Steels JC; Rinaldo F Front Neurol; 2023; 14():1144183. PubMed ID: 37588667 [TBL] [Abstract][Full Text] [Related]